43 results
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
7 Sep 23
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
4:21pm
, and other filings with the SEC. These risks and uncertainties may be amplified by current economic situations, including
inflation, supply chain issues
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
29 Aug 23
Celularity Announces Multi-year Research Collaboration Services Agreement with Regeneron
9:15am
, and other filings with the SEC. These risks and uncertainties may be amplified by current economic situations, including inflation, supply chain issues
424B5
CELU
Celularity Inc - Ordinary Shares
28 Jul 23
Prospectus supplement for primary offering
4:24pm
;
difficulties arising from reliance on third-party licenses, or supply-chain or manufacturing challenges;
risks from any strategic alliances or licensing
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
27 Apr 23
Other Events
5:01pm
. These risks and uncertainties may be amplified by current economic situations, including inflation, supply chain issues and overall economic
424B5
rzhcyz5 es
6 Apr 23
Prospectus supplement for primary offering
9:03pm
8-K
8ki1rypf2b
6 Oct 22
Departure of Directors or Certain Officers
4:08pm
424B5
8prg3 iblw9b
15 Sep 22
Prospectus supplement for primary offering
4:06pm
424B5
6fm30cqk 7rbdyitp79n
8 Sep 22
Prospectus supplement for primary offering
8:46am
424B3
isnpzek 25ubg
24 Aug 22
Prospectus supplement
4:54pm
424B3
9wr4divg40i85f01
24 Aug 22
Prospectus supplement
4:52pm
S-3
bto11if7y0h
11 Aug 22
Shelf registration
4:29pm
POS AM
8g2vz3lf9nrqis954
11 Aug 22
Prospectus update (post-effective amendment)
4:23pm
POS AM
sbxif4uf8rc
11 Aug 22
Prospectus update (post-effective amendment)
4:20pm
8-K
EX-99.1
1ra9i
17 Jun 22
Other Events
4:57pm
424B3
a5iliqt808q ulktf72
1 Jun 22
Prospectus supplement
4:06pm